University of Utah Clinical Neurosciences Center

Salt Lake City, Utah 84312

3 studies enrolling now · 13 studies all time

What they study most

Acute Non-cardioembolic Ischemic Stroke, Amyotrophic Lateral Sclerosis, Congenital Myotonic Dystrophy, DM1, Duchenne Muscular Dystrophy, Focal Epilepsy, Focal Onset Seizures, Heart Failure, High-risk Transient Ischemic Attack, Huntingtons Disease, Muscular Dystrophy, Duchenne, Myotonic Dystrophy

Studies at this site

• A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures — Recruiting now
• Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1 — Recruiting now
• A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3) — Recruiting now
• Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy — Recruiting now
• An Open-label Study of XEN1101 in Epilepsy — Enrolling by invitation
• Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy — Running, not enrolling
• A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke — Completed
• Study of Fordadistrogene Movaparvovec in Early Stage Duchenne Muscular Dystrophy — Stopped early
• A Study to Understand the Long-term Safety and Effects of an Experimental Gene Therapy for Duchenne Muscular Dystrophy. — Stopped early
• A Study to Evaluate the Safety and Tolerability of PF-06939926 Gene Therapy in Duchenne Muscular Dystrophy — Stopped early
• Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40% — Completed
• A Study to Evaluate the Efficacy and Safety of Intrathecally Administered RO7234292 (RG6042) in Participants With Manifest Huntington's Disease — Completed
• A Multi-Center Controlled Screening Trial of Safety and Efficacy of Lithium Carbonate in Subjects With Amyotrophic Lateral Sclerosis (ALS) — Completed